Sionna Therapeutics, Inc. · NASDAQ:SION
JPMorgan Chase & Co's stake in Sionna Therapeutics, Inc. fell to 4.40% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Oct 31, 2025
JPMorgan Chase & Co's stake in Sionna Therapeutics, Inc. fell to 4.40%, 1,980,626 shares, as a passive investor on Sep 30, 2025. Filed Oct 31, 2025 (Schedule 13G/A).
- Stake
- 4.40%
- Shares
- 1,980,626
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JPMORGAN CHASE & CO. | 4.40% | 1,980,626 |
Source
Related
- Sionna Therapeutics, Inc.
- JPMorgan Chase & Co
- Sionna Therapeutics, Inc. shareholders
- Schedule 13G · JPMorgan Chase & Co · Jul 30, 2025
- Form 4 · Ra Capital Management, L.P. · Sep 21, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Sep 21, 2026
- Form 4 · Ridloff Elena · Sep 18, 2026
- Form 4 · McKee Charlotte · Sep 18, 2026
- Form 4 · Fitzpatrick Jennifer · Sep 18, 2026